Surge

What it does

"Surge is a pioneering company in the fields of Artificial Intelligence, Deeptech, Health, and Medtech, offering an innovative platform to decrypt the immune system and enhance the prediction of critical medical outcomes. By focusing on improving the accuracy of risk assessments through the identification of predictive biological signatures, Surge aims to revolutionize clinical patient management and facilitate transparent risk communication with patients. Originating from the esteemed Brice Gaudilliere lab at Stanford, Surge's data-driven solution utilizes multi-omics data to predict outcomes, employing cutting-edge measurement methods like mass cytometry and proximity extension assays. Through the integration of high-quality omics data, advanced predictive modeling, and the selection of reliable biomarkers, Surge is at the forefront of shaping the future of precision health. This innovative approach underscores Surge's commitment to advancing healthcare through technology and data-driven insights."